The Bill & Melinda Gates Foundation and the UK Government’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) have joined the CARB-X partnership, which supports global scientific research to develop new vaccines, preventatives and other products against drug-resistant bacterial infecti
EU member states have voted to impose a near- total ban on neonicotinoid insecticides – the most widely used class of insecticides in the world – across the region. The ban will cover all crops grown outdoors, but growers will still be free to use them in greenhouses across the EU.
Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, has reached an agreement to be acquired by Madison Dearborn Partners (MDP), a leading private equity firm based in Chicago.
The Drug, Chemical & Associated Technologies Association (DCAT) has announced the winners of four scholarships presented at the Intel International Science & Engineering Fair (Intel ISEF) Special Awards Ceremony on 17 May in Pittsburgh, Pennsylvania.
This year’s InformEx/CPhI North America event was buzzing, with thousands of attendees and over 25 high-profile speakers in a conference programme focused on the latest drug development innovations and manufacturing technologies.
Agrichemical giant Bayer has won EU antitrust approval for its US$62.5 billion acquisition of Monsanto, Reuters reports, on condition that Bayer sells off substantial parts of its business. If the merger goes ahead, it would create a company with control of more than a quarter of the world’s seed and pesticides market.
Chemicals company Evonik and electronics giant Siemens have launched a joint research project to convert carbon dioxide (CO2) into speciality chemicals, using electricity from renewable sources and bacteria.
Paints, coatings and speciality chemicals multinational AkzoNobel has announced the sale of its entire speciality chemicals business to The Carlyle Group and Singaporean investment fund GIC for €10.1 billion (US$12.3 billion). The sale is expected to be complete by the end of the year.
In a press release, the company said a private sale would be in the best interests of AkzoNobel and its stakeholders. The Carlyle Group has a global presence and the financial capacity to enable the speciality chemicals business to achieve its full potential.